Physician profile
Jack L Schaeffer
NPI 1598730582
$59,775.44
in general payments reported to CMS, 2019-2025
20 companies · $13K in 2025
The $13K reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2020: $7,038 · 2021: $3,029 · 2022: $4,487 · 2023: $4,398 · 2024: $9,150 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $17K · Honoraria: $5,500 · Food and Beverage: $2,083 · Travel and Lodging: $1,506.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $17,425.00 |
| Honoraria | $5,500.00 |
| Food and Beverage | $2,083.03 |
| Travel and Lodging | $1,506.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $24,803.65 | 2019-2022 | |
| Topcon Healthcare, INC. | $9,035.28 | 2024-2025 | |
| Bausch & Lomb Americas INC. | $4,866.22 | 2022-2025 | Miebo, Xiidra, Doctors Allergy Formula |
| Abbvie INC. | $4,705.79 | 2022-2023 | Vuity, Lumigan, Combigan |
| Thea Pharma INC. | $3,190.03 | 2023-2024 | Iyuzeh |
| Tarsus Pharmaceuticals, INC. | $3,012.51 | 2024-2025 | Xdemvy |
| Alcon Vision LLC | $2,981.39 | 2019-2025 | Tryptyr |
| Tearlab Corp | $1,750.00 | 2024 | Scoutpro Osmolarity System |
| Heru, INC. | $1,500.00 | 2025 | Heru Hmd |
| Glaukos Corporation | $1,350.00 | 2025 | |
| Kala Pharmaceuticals, INC. | $600.00 | 2020 | |
| Shire North American Group INC | $421.60 | 2019 | |
| Harrow Eye, LLC | $400.13 | 2024-2025 | Triesence, Vevye |
| Carl Zeiss Meditec, INC. | $297.64 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $279.37 | 2020-2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Topcon Corporation | $238.37 | 2024 | |
| Sun Pharmaceutical Industries INC. | $130.92 | 2021-2022 | |
| Galderma Laboratories, L.P. | $88.79 | 2019 | |
| Sight Sciences, INC. | $71.54 | 2025 | Tearcare System |
| Oyster Point Pharma, INC. | $52.21 | 2023 | Tyrvaya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Schaeffer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.